Publications
2023
Scholarly publications
Keuper-Navis, M., Walles, M., Poller, B., Myszczyszyn, A., van der Made, T. K., Donkers, J., Amirabadi, H. E., Wilmer, M. J., Aan, S., Spee, B., Masereeuw, R., & van de Steeg, E. (2023). The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug development. Pharmacological Research, [106853]. https://doi.org/10.1016/j.phrs.2023.106853
Faucher, Q., van der Made, T. K., De Lange, E., & Masereeuw, R. (2023). Blood-brain barrier perturbations by uremic toxins: key contributors in chronic kidney disease-induced neurological disorders? European Journal of Pharmaceutical Sciences, 187, 1-8. [106462]. https://doi.org/10.1016/j.ejps.2023.106462
2019
Professional publications
van der Made, T. K., Fedecostante, M., Scotcher, D., Rostami-Hodjegan, A., Sastre Toraño, J., Middel, I., Koster, A. S., Gerritsen, K. G., Jankowski, V., Jankowski, J., Hoenderop, J. G. J., Masereeuw, R., & Galetin, A. (2019). Quantitative Translation of Microfluidic Transporter in Vitro Data to in Vivo Reveals Impaired Albumin-Facilitated Indoxyl Sulfate Secretion in Chronic Kidney Disease. Molecular Pharmaceutics, 16, 4551-4562. https://doi.org/10.1021/acs.molpharmaceut.9b00681